According to Fortune Business Insights, the global Continuous Renal Replacement Therapy (CRRT) market size was valued at USD 1,245.90 million in 2025 and is projected to grow from USD 1341.90 million in 2026 to USD 2,521.70 million by 2034, exhibiting a CAGR of 8.20% during the forecast period. North America dominated the continuous renal replacement therapy market with a market share of 39.72% in 2025.
The continuous renal replacement therapy market is focused on therapies used for the gradual and continuous removal of waste products, excess fluids, and electrolytes from the blood of critically ill patients with acute kidney injury and other severe renal conditions. Continuous renal replacement therapy is particularly relevant in intensive care settings where patients may not tolerate conventional intermittent dialysis. Growing awareness of acute kidney injury, increasing critical care requirements, improvements in renal replacement technologies, and the increasing use of advanced healthcare infrastructure are supporting the development of the continuous renal replacement therapy market. In 2026, the continuous renal replacement therapy market is expected to benefit from the increasing adoption of advanced renal care technologies and the growing need for specialized critical care treatment.
Continue reading for more details:
https://www.fortunebusinessinsights.com/continuous-renal-replacement-therapy-crrt-market-102547
The continuous renal replacement therapy market is segmented by product into disposables and systems. Disposables include filters, bloodlines, replacement fluids, and other consumable components required during therapy. The recurring need for these products contributes to their importance within the continuous renal replacement therapy market. Systems include machines and equipment used to administer and monitor CRRT procedures. Technological improvements in these systems are supporting healthcare professionals by enabling improved treatment management, monitoring, and operational efficiency in intensive care environments.
Based on modality, the continuous renal replacement therapy market is divided into continuous venovenous hemofiltration, continuous venovenous hemodialysis, continuous venovenous hemodiafiltration, and others. Continuous venovenous hemofiltration is widely used because it provides continuous fluid and solute removal and can be applied to critically ill patients requiring controlled renal support. Continuous venovenous hemodialysis provides continuous removal of waste products through diffusion, while continuous venovenous hemodiafiltration combines diffusion and convection to provide comprehensive clearance. The availability of multiple modalities allows healthcare professionals to select treatment approaches according to individual patient requirements.
By patient type, the continuous renal replacement therapy market is segmented into adults and pediatrics. Adults represent a major patient group because acute kidney injury and other severe renal complications are frequently observed among critically ill adult patients. Pediatric applications are also important, particularly in specialized intensive care environments where renal support must be carefully adjusted according to patient requirements. Increasing availability of specialized critical care facilities is supporting the application of continuous renal replacement therapy across both patient categories.
Based on end user, the continuous renal replacement therapy market is categorized into hospitals, specialty clinics, and others. Hospitals account for a major share because CRRT is primarily administered in intensive care units and other specialized hospital departments. Specialty clinics and other healthcare facilities also contribute to market development as renal care services become increasingly specialized. The expansion of hospital infrastructure and critical care capacity is supporting demand for CRRT products and systems.
The continuous renal replacement therapy market is experiencing growth due to the increasing incidence and clinical recognition of acute kidney injury among critically ill patients. Acute kidney injury can occur in patients affected by severe illnesses, infections, cardiovascular complications, and other critical conditions. Continuous renal replacement therapy provides an important renal support option for patients who require gradual fluid and solute management. Increasing awareness among healthcare professionals regarding the clinical benefits of CRRT is supporting its adoption in intensive care settings.
The growing number of intensive care units and improvements in critical care infrastructure are also contributing to the continuous renal replacement therapy market. Hospitals are investing in advanced equipment and technologies to provide comprehensive treatment for critically ill patients. The increasing availability of specialized healthcare professionals and improved monitoring capabilities is encouraging the use of advanced renal replacement therapies.